KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Change in Receivables (2016 - 2025)

Labcorp Holdings' Change in Receivables history spans 17 years, with the latest figure at -$30.9 million for Q2 2025.

  • For Q2 2025, Change in Receivables fell 705.88% year-over-year to -$30.9 million; the TTM value through Mar 2025 reached $36.0 million, down 80.27%, while the annual FY2025 figure was $125.5 million, 139.96% up from the prior year.
  • Change in Receivables for Q2 2025 was -$30.9 million at Labcorp Holdings, down from $170.8 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $187.1 million in Q1 2024 and bottomed at -$146.7 million in Q1 2021.
  • The 5-year median for Change in Receivables is -$10.6 million (2022), against an average of -$994444.4.
  • The largest annual shift saw Change in Receivables skyrocketed 1275.0% in 2023 before it tumbled 705.88% in 2025.
  • A 5-year view of Change in Receivables shows it stood at -$131.8 million in 2021, then skyrocketed by 110.09% to $13.3 million in 2022, then tumbled by 624.81% to -$69.8 million in 2023, then tumbled by 30.23% to -$90.9 million in 2024, then skyrocketed by 66.01% to -$30.9 million in 2025.
  • Per Business Quant, the three most recent readings for LH's Change in Receivables are -$30.9 million (Q2 2025), $170.8 million (Q1 2025), and -$90.9 million (Q4 2024).